Protein-Losing Enteropathy in the Failing Fontan: Treatment With Angiotensin Receptor Neprilysin Inhibitor.
| Autor: | Sanders E; Arkansas Children's Hospital, Little Rock, Arkansas, USA., Knecht K; Arkansas Children's Hospital, Little Rock, Arkansas, USA., Zakaria D; Arkansas Children's Hospital, Little Rock, Arkansas, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | JACC. Case reports [JACC Case Rep] 2024 Jun 12; Vol. 29 (14), pp. 102395. Date of Electronic Publication: 2024 Jun 12 (Print Publication: 2024). |
| DOI: | 10.1016/j.jaccas.2024.102395 |
| Abstrakt: | Angiotensin receptor neprilysin inhibitor is the standard of care for systolic heart failure in adults. In addition, its use in adults with failing systemic right ventricles and diastolic heart failure is promising. This study reports our experience with this drug for protein-losing enteropathy secondary to Fontan failure in pediatrics. Competing Interests: The authors have reported that they have no relationships relevant to the contents of this paper to disclose. (© 2024 The Authors.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|